ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma

Zheng, Ruinian; Lai, Guowei; Li, Rongfa; Hao, Yanyan; Cai, Limin*; Jia, Jun*南方医科大学; 东莞市人民医院
Journal of Gastrointestinal Oncology2021-2DOI: 10.21037/jgo-20-574
7被引4阅读
引用收藏
分享

摘要

Background: The minichromosome maintenance (MCM) protein complex is important for DNA replication. Moreover, the expression of specific MCM complex components has been associated with the survival of hepatocellular carcinoma (HCC) patients. However, the expression and functional roles of minichromosome maintenance complex component 4 (MCM4) in HCC development and progression have not yet been explored. We analyzed the expression and clinical significance of MCM4, including its association with liver cancer patient survival. @@@ Methods: Oncomine, UALCAN, and HCCDB (a database of HCC expression atlas) were used to characterize the expression of MCM4 in tumor and normal tissues. The expression of MCM4 at the protein level was confirmed based on immunohistochemistry (IHC) data obtained from the Human Protein Atlas (HPA) database. The level of MCM4 was measured in tumor and adjacent normal tissues by RT-qPCR, western blot and IHC staining. The copy number alterations (CNAs) and mutations in MCM4 were analyzed by cBioPortal, whereas the co-expression genes of MCM4 in HCC were obtained from Oncomine, and used for gene ontology and pathway analysis via the NetworkAnalyst 3.0 tool, to explore the predictive signaling pathway in HCC. @@@ Results: The levels of MCM4 messenger (m)RNA and protein were found to be significantly higher in liver cancer tissues than in normal liver tissues. Kaplan-Meier analysis showed that the upregulation of MCM4 was significantly negatively correlated with the survival of HCC patients. @@@ Conclusions: Our data suggest that MCM4 may be used as a potential prognostic marker and therapeutic target for HCC.

学科与关键词

关键词
Minichromosome maintenance complex component 4 (MCM4)hepatocellular carcinoma (HCC)cancer progressionclinical outcomessurvivalmultiomics analysis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Gastrointestinal Oncology
发表日期
2021-02
卷期
第 12 卷, 第 1 期
页码
153-173
DOI
10.21037/jgo-20-574
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
Medical Scientific Research Foundation of the Guangdong Province of China [B2018064]; Shenzhen Science and Technology Innovation Commission Project [GJHZ20180420180754917, ZDSYS20190902092855097, JCYJ20170306170933370, JCYJ20180508152437368]; Shenzhen Sanming Project [SZSM201612041]

作者

  • Z

    Zheng, Ruinian (第一作者)

    dongguan peoples hosp · southern med univ

  • L

    Lai, Guowei

    dongguan peoples hosp · southern med univ

查看全部 6 位作者收起作者
  • L

    Li, Rongfa

    dongguan peoples hosp · southern med univ

  • H

    Hao, Yanyan

    dongguan peoples hosp · southern med univ

  • C

    Cai, Limin (通讯)

    dongguan peoples hosp · southern med univ

  • J

    Jia, Jun (通讯)

    dongguan peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417